Medicine and Dentistry
Lung Cancer
100%
Computer Assisted Tomography
92%
Lung Cancer Screening
68%
Neoplasm
62%
Lung
49%
Lung Nodule
44%
Cancer
39%
Non Small Cell Lung Cancer
36%
Multidetector Computed Tomography
35%
Low Drug Dose
35%
Malignant Neoplasm
29%
Dual Energy Computed Tomography
28%
Diseases
28%
Lung Adenocarcinoma
27%
Adenocarcinoma
24%
Pneumonia
23%
Diagnosis
23%
Immune Checkpoint Inhibitor
21%
Infection
20%
COVID-19
18%
Ground Glass Opacity
18%
Halo Sign
17%
Biopsy Technique
17%
Multimodality Imaging
17%
Silo-Filler's Disease
16%
Lower Respiratory Tract Infection
15%
Surgery
15%
Organizing Pneumonia
14%
Immunity
14%
Thorax Radiography
13%
Cancer Staging
13%
Thoracic Aorta
13%
Differential Diagnosis
13%
Radiation Dose Reduction
13%
Respiratory Disease
12%
Image Quality
11%
Patient with Pneumonia
11%
Biological Marker
11%
Acute Leukemia
11%
Acute Myeloid Leukemia
11%
Immune Reconstitution Inflammatory Syndrome
11%
Circulating Tumor DNA
11%
Computed Tomography Angiography
11%
Thoracic Oncology
11%
Respiratory Tract Infection
11%
Polyethylene Terephthalate
11%
Cylindroma
11%
Screening
11%
Respiratory Medicine
11%
Immunotherapy
11%
Keyphrases
Lung Cancer
63%
Lung Cancer Screening
40%
Computed Tomography
29%
Adenocarcinoma
17%
Reversed Halo Sign
17%
Pneumonitis
17%
Patient Management
16%
Immune Checkpoint Inhibitors
15%
Invasive Adenocarcinoma
15%
Early-stage Lung Cancer
14%
Lung Nodule
14%
Image Evaluation
13%
Differential Diagnosis
13%
Resectable Lung Cancer
12%
Tumor
12%
Pneumonia
12%
Ground-glass Opacity
12%
Surgical Resection
12%
Intraoperative Imaging
11%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
11%
Strategic Management
11%
Subsolid Pulmonary Nodule
11%
Postoperative Complications
11%
Dual-energy CT
11%
Pre-neoplasia
11%
Preneoplasia
11%
Interventional Pulmonology
11%
Bronchoscopic
11%
Lung Adenocarcinoma
11%
Lung
10%
Adaptive Statistical Iterative Reconstruction
10%
Positron Emission Tomography-computed Tomography (PET-CT)
10%
TNM8
9%
Non-small Cell Lung Cancer (NSCLC)
9%
Radiologists
9%
Pulmonary Disease
9%
Nodule
9%
Imaging Modalities
8%
Confidence Interval
8%
Neoadjuvant Chemotherapy
8%
Incidental
8%
Computational Imaging
8%
Low-dose Computed Tomography Screening
8%
Advanced Lung Adenocarcinoma
7%
Risk Factors
7%
Low-dose Computed Tomography
7%
Increased Mortality
7%
Healthcare Resource Utilization
7%
Glass Components
7%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
7%